Search for Clinical Trial Results
Chondrosarcoma - 30 Studies Found
Status | Study |
Active, not recruiting |
Study Name: Imatinib in Patients With Desmoid Tumor and Chondrosarcoma Condition:
Date: 2009-06-25 Interventions: Drug: Imatinib Mesylate 800 mg p.o./day (400 mg b.i.d.) for a maximum of 24 months |
Recruiting |
Study Name: Trial of Pazopanib in Patients With Solitary Fibrous Tumor and Extraskeletal Myxoid Chondrosarcoma Condition:
Date: 2014-02-14 Interventions: Drug: Pazopanib Treatment will continue until disease progression, development of unacceptable toxicity, |
Active, not recruiting |
Study Name: Vismodegib in Treating Patients With Advanced Chondrosarcomas Condition:
|
Recruiting |
Study Name: Sirolimus and Cyclophosphamide in Metastatic or Unresectable Myxoid Liposarcoma and Chondrosarcoma Condition:
|
Completed |
Study Name: Gemcitabine and Docetaxel in Treating Patients With Recurrent Osteosarcoma (Closed to Accrual as of 12/21/06) or Ewing's Sarcoma or Unresectable or Locally Recurrent Chondrosarcoma Condition: Sarcoma Date: 2003-12-10 Interventions:
|
Completed |
Study Name: IPI-926 Extension Protocol for Continuation of Treatment With IPI-926 Condition:
Date: 2012-05-29 Interventions: Drug: IPI-926 IPI-926 is administered orally as a capsule formulation, as a fixed dose in mg/day. Patien |
Completed |
Study Name: A Trial of Perifosine in Patients With Chemo-Insensitive Sarcomas Condition:
|